Eva Rodansky
Education
MS, Biology, City of Hope-Beckman Research Institute
BS, Microbiology, University of Michigan Dearborn
Research Interests
Transcriptional reprogramming of lineage plastic prostate cancer
Role of tumor microenvironment in invasion and metastasis
Contact
Email: rodansky@umich.edu
Mentors who have altered my life: My mentors in Olympic sports reform and anti-abuse advocacy, Nancy Hogshead-Makar and Ed Williams. We are still collaborating on sports reform at the federal level.
In my time off, I enjoy: Mountain biking, running, snowboarding, ice and inline skating, going to punk shows.
What profession, other than your own, would you enjoy? I would have liked flying the Survival Flight helicopter at U of M.
Recent Publications
Westbrook TC, Guan X, Rodansky E, Flores D, Liu CJ, Udager AM, Patel RA, Haffner MC, Hu YM, Sun D, Beer TM, Foye A, Aggarwal R, Quigley DA, Youngren JF, Ryan CJ, Gleave M, Wang Y, Huang J, Coleman I, Morrissey C, Nelson PS, Evans CP, Lara P, Reiter RE, Witte O, Rettig M, Wong CK, Weinstein AS, Uzunangelov V, Stuart JM, Thomas GV, Feng FY, Small EJ, Yates JA, Xia Z, & Alumkal JJ. Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity. Nature Communications (2022). DOI: 10.1038/s41467-022-32701-6
Kim DH, Sun D, Storck WK, Welker Leng KR, Jenkins C, Coleman DJ, Sampson DA, Guan X, Kumaraswamy A, Rodansky ES, Urrutia JA, Schwartzman J, Zhang C, Beltran H, Labrecque MP, Morrissey C, Lucas JM, Coleman I, Nelson PS, Corey E, Handelman SK, Sexton JZ, Aggarwal R, Abida W, Feng FY, Small EJ, Spratt DE, Bankhead III A, Rao A, Gesner EM, Attwell S, Lakhotia S, Campeau E, Yates JA, Xia Z, & Alumkal JJ. BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program. Clinical Cancer Research (2021). DOI: 10.1158/1078-0432.CCR-20-4968
Rodansky ES, Johnson LA, Huang S, Spence JR, & Higgins PD. Intestinal organoids: a model of intestinal fibrosis for evaluating anti-fibrotic drugs. Experimental and Molecular Pathology (2015). DOI: 10.1016/j.yexmp.2015.03.033
Sisson TH, Ajayi IO, Subbotina N, Dodi AE, Rodansky ES, Chibucos LN, Kim KK, Keshamouni VG, White ES, Zhou Y, Higgins PD, Larsen SD, Neubig RR, & Horowitz JC. Inhibition of myocardin-related transcription factor/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosis. The American Journal of Pathology (2015). DOI: 10.1016/j.ajpath.2014.12.005